Azitra, Inc. Announces Q2 2025 Results and Provides Business Updates
BRANFORD, Conn., Aug. 11, 2025 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision der...
What potential macro or sectorâspecific factors could amplify or mitigate the impact of this news on AZTR's stock price?
How might the earnings results affect analyst coverage, target price revisions, or consensus estimates?
Did the company address any operational or strategic initiatives that could influence longâterm growth prospects?
15 days ago